Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. <i>Molecules</i> 2021, <i>26</i>, 866
The authors wish to make the following changes to the paper [...]
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-02-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/29/4/902 |
| _version_ | 1797297372310536192 |
|---|---|
| author | Basma G. Eid Thikryat Neamatallah Abeer Hanafy Hany M. El-Bassossy Lenah Binmahfouz Hibah M. Aldawsari Atif Hasan Gamal Abd El-Aziz Kiran Vemuri Alexandros Makriyannis |
| author_facet | Basma G. Eid Thikryat Neamatallah Abeer Hanafy Hany M. El-Bassossy Lenah Binmahfouz Hibah M. Aldawsari Atif Hasan Gamal Abd El-Aziz Kiran Vemuri Alexandros Makriyannis |
| author_sort | Basma G. Eid |
| collection | DOAJ |
| description | The authors wish to make the following changes to the paper [...] |
| first_indexed | 2024-03-07T22:20:25Z |
| format | Article |
| id | doaj.art-f8661fcea97a4f9e86132aafca99a8d5 |
| institution | Directory Open Access Journal |
| issn | 1420-3049 |
| language | English |
| last_indexed | 2024-03-07T22:20:25Z |
| publishDate | 2024-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj.art-f8661fcea97a4f9e86132aafca99a8d52024-02-23T15:29:12ZengMDPI AGMolecules1420-30492024-02-0129490210.3390/molecules29040902Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. <i>Molecules</i> 2021, <i>26</i>, 866Basma G. Eid0Thikryat Neamatallah1Abeer Hanafy2Hany M. El-Bassossy3Lenah Binmahfouz4Hibah M. Aldawsari5Atif Hasan6Gamal Abd El-Aziz7Kiran Vemuri8Alexandros Makriyannis9Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi ArabiaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi ArabiaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi ArabiaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi ArabiaDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi ArabiaDepartment of Anatomy and Embryology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh 33516, EgyptDepartment of Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi ArabiaCenter for Drug Discovery, Northeastern University, Boston, MA 02115, USACenter for Drug Discovery, Northeastern University, Boston, MA 02115, USAThe authors wish to make the following changes to the paper [...]https://www.mdpi.com/1420-3049/29/4/902n/a |
| spellingShingle | Basma G. Eid Thikryat Neamatallah Abeer Hanafy Hany M. El-Bassossy Lenah Binmahfouz Hibah M. Aldawsari Atif Hasan Gamal Abd El-Aziz Kiran Vemuri Alexandros Makriyannis Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. <i>Molecules</i> 2021, <i>26</i>, 866 Molecules n/a |
| title | Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. <i>Molecules</i> 2021, <i>26</i>, 866 |
| title_full | Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. <i>Molecules</i> 2021, <i>26</i>, 866 |
| title_fullStr | Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. <i>Molecules</i> 2021, <i>26</i>, 866 |
| title_full_unstemmed | Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. <i>Molecules</i> 2021, <i>26</i>, 866 |
| title_short | Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. <i>Molecules</i> 2021, <i>26</i>, 866 |
| title_sort | correction eid et al interference with tgfβ1 mediated inflammation and fibrosis underlies reno protective effects of the cb1 receptor neutral antagonists am6545 and am4113 in a rat model of metabolic syndrome i molecules i 2021 i 26 i 866 |
| topic | n/a |
| url | https://www.mdpi.com/1420-3049/29/4/902 |
| work_keys_str_mv | AT basmageid correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT thikryatneamatallah correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT abeerhanafy correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT hanymelbassossy correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT lenahbinmahfouz correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT hibahmaldawsari correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT atifhasan correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT gamalabdelaziz correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT kiranvemuri correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 AT alexandrosmakriyannis correctioneidetalinterferencewithtgfb1mediatedinflammationandfibrosisunderliesrenoprotectiveeffectsofthecb1receptorneutralantagonistsam6545andam4113inaratmodelofmetabolicsyndromeimoleculesi2021i26i866 |